We've got a need to acquire products in the near term with all our patent expirations,

This is consistent with our strategy to participate in the generic market for Pfizer products that become subject to generic competition.

All of these [technologies] are more near-term than having a refrigerator or closet full of RFID tagged products.

It is our top pick. I like the lack of patent expirations...They have a portfolio of new products.

It is our top pick. I like the lack of patent expirations... They have a portfolio of new products.

Although Cisco's lowered stock price may be seductive to investors, we believe that there is still near term downside to the stock, ... It is clearer than ever to us that the current Cisco appears to be merely a shadow of its former self.